Glanbia raises FY EPS guidance, volumes up across all units year-to-date

By Reuters News

- Glanbia PLC GL9.I:

  • GLANBIA - GROUP LIKE-FOR-LIKE REVENUE +9.9% FOR NINE MONTHS ENDED OCT 3 WITH VOLUME GROWTH ACROSS ALL THREE SEGMENTS

  • GLANBIA - Q3 OPTIMUM NUTRITION LFL REVENUE GROWTH OF 26.9% (+0.8% VOLUME; +26.1% PRICE)

  • GLANBIA - OPTIMUM NUTRITION REVENUE +25.8% YEAR-TO-DATE DRIVEN BY STRONG CATEGORY GROWTH, MARKET SHARE GAINS, NEW DISTRIBUTION, PRICING ACTIONS

  • GLANBIA - FY PERFORMANCE NUTRITION REVENUE GUIDANCE TO 16% TO 17% (PREVIOUSLY 12% TO 14%);

  • GLANBIA - RAISES FY GUIDANCE TO ADJUSTED EPS GROWTH OF 22% TO 24% CONSTANT CURRENCY (PREVIOUSLY 17% TO 20%).

  • GLANBIA - FY DAIRY NUTRITION EBITDA GUIDANCE TO $175-180 MILLION (PREVIOUSLY $170-180 MILLION); ALL OTHERS UNCHANGED

  • GLANBIA - PERFORMANCE NUTRITION REVENUE +18.0% YEAR-TO-DATE, HEALTH & NUTRITION REVENUE + 9.8%, DAIRY NUTRITION REVENUE +2.1%

  • GLANBIA - WENDY CHANG SMITH APPOINTED CFO DESIGNATE, EFFECTIVE AS CFO AND EXECUTIVE DIRECTOR FROM 31 MARCH 2027

  • GLANBIA - HEALTH & NUTRITION PRICING DECREASE WAS PREDOMINANTLY DRIVEN BY SOME TARIFF REFUNDS AND VOLUME REBATES TO CUSTOMERS

Further company coverage: GL9.I

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.